Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

101 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Production of antigen-specific human monoclonal antibodies: comparison of mice carrying IgH/kappa or IgH/kappa/lambda transloci.
Magadán S, Valladares M, Suarez E, Sanjuán I, Molina A, Ayling C, Davies SL, Zou X, Williams GT, Neuberger MS, Brüggemann M, Gambón F, Diaz-Espada F, González-Fernandez A. Magadán S, et al. Among authors: valladares m. Biotechniques. 2002 Sep;33(3):680, 682, 684 passim. doi: 10.2144/02333dd04. Biotechniques. 2002. PMID: 12238778 Free article.
Assessment of the evolution of cancer treatment therapies.
Arruebo M, Vilaboa N, Sáez-Gutierrez B, Lambea J, Tres A, Valladares M, González-Fernández A. Arruebo M, et al. Among authors: valladares m. Cancers (Basel). 2011 Aug 12;3(3):3279-330. doi: 10.3390/cancers3033279. Cancers (Basel). 2011. PMID: 24212956 Free PMC article.
Cholesterol goals, statin use and residual cardiovascular risk estimated by SMART score: Study of a Nicaraguan population.
Rizo Rivera GO, Valladares MJ, Toledo Vargas HM, Chavez E, Garcia de la Rocha AA, Urcuyo Hernandez LA, Meneses Mercado JD. Rizo Rivera GO, et al. Among authors: valladares mj. Int J Cardiol Cardiovasc Risk Prev. 2023 Jun 23;18:200192. doi: 10.1016/j.ijcrp.2023.200192. eCollection 2023 Sep. Int J Cardiol Cardiovasc Risk Prev. 2023. PMID: 37427093 Free PMC article.
A randomised phase 2 study comparing different dose approaches of induction treatment of regorafenib in previously treated metastatic colorectal cancer patients (REARRANGE trial).
Argilés G, Mulet N, Valladares-Ayerbes M, Viéitez JM, Grávalos C, García-Alfonso P, Santos C, Tobeña M, García-Paredes B, Benavides M, Cano MT, Loupakis F, Rodríguez-Garrote M, Rivera F, Goldberg RM, Cremolini C, Bennouna J, Ciardiello F, Tabernero JM, Aranda E; Spanish Cooperative Group for the Treatment of Digestive Tumors (TTD) and UNICANCER GI; The, REARRANGE investigators; Principal investigator; Argilés G, Tabernero J; Steering Committee; Investigators. Argilés G, et al. Eur J Cancer. 2022 Dec;177:154-163. doi: 10.1016/j.ejca.2022.09.037. Epub 2022 Oct 14. Eur J Cancer. 2022. PMID: 36335783 Free article. Clinical Trial.
101 results